Ortega A.
221
Coauthors
21
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 5 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Cáncer | 6 |
| Obesidad | 5 |
| Bioquímica | 4 |
| Enfermedad cardiovascular | 3 |
| Medicina interna | 3 |
| Epidemiología | 2 |
| Salud mental | 2 |
| Farmacología | 2 |
| Dolor | 2 |
| Diabetes | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Enfermedades | 18 |
| Farmacología y terapéutica | 9 |
| Fisiología humana | 8 |
| Medicina y salud | 6 |
| Salud y seguridad personal | 3 |
| Ginecología, obstetricia, pediatría, geriatría | 3 |
| Bioquímica | 1 |
| Psicología aplicada | 1 |
| Medicina forense; incidencia de enfermedades | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 21 |
| Google Scholar | 1 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Valmore Bermúdez | 21 |
| Rojas-Quintero J. | 15 |
| Salazar-Vílchez J. | 13 |
| González M.C. | 12 |
| Rojas M. | 12 |
| Nava M. | 11 |
| Chávez-Castillo M. | 11 |
| Cano-Ponce C. | 6 |
| Durán P. | 5 |
| D’marco L. | 4 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
ReviewAbstract: Depression is currently recognized as a crucial problem in everyday clinical practice, in light of ePalabras claves:Autores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Valmore BermúdezFuentes:scopusDepression as an immunometabolic disorder: Exploring shared pharma-cotherapeutics with cardiovascular disease
ReviewAbstract: Modern times have seen depression and cardiovascular disease (CVD) become notorious public health coPalabras claves:Cardiovascular disease, Chronic inflammation, Depression, Insulin Resistance, metabolism, Oxidative StressAutores:Chávez-Castillo M., Nava M., Nuñez V., Ortega A., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Valmore BermúdezFuentes:scopusMetabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?
ReviewAbstract: Depression is one of the most common psychiatric disorders, and has become an epidemic in modern medPalabras claves:Cardiovascular disease, Cardiovascular Risk, Chronic inflammation, Depression, Metabolic syndrome, Selective serotonin reuptake inhibitors, Type 2 Diabetes mellitusAutores:Chávez-Castillo M., Fuenmayor J., Lameda V., Nava M., Ortega A., Rojas-Quintero J., Valmore Bermúdez, Velasco M.Fuentes:scopusMetabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches
ReviewAbstract: The constant changes in cancer cell bioenergetics are widely known as metabolic repro-gramming. ReprPalabras claves:Carbohydrates, Energy metabolism, immunotherapy, inflammation, Metabolic reprogramming, neoplasms, tumor microenvironmentAutores:de Sanctis J.B., Galbán N., Garrido B., González M.C., Navarro C., Ortega A., Santeliz R., Valmore Bermúdez, Vera I.Fuentes:scopusSGLT2i and GLP-1RA in Cardiometabolic and Renal Diseases: From Glycemic Control to Adipose Tissue Inflammation and Senescence
ReviewAbstract: Background. Over the last few years, the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) aPalabras claves:Autores:D’marco L., Morillo V., Nava M., Ortega A., Parra H., Rojas-Quintero J., Suarez M.K., Teruel J.L., Valmore Bermúdez, Villasmil N.Fuentes:scopus